Working with Individuals who use Cocaine and Methamphetamine: Reordering Priorities

Current Status
Not Enrolled
Price
Free
Get Started
Log In to Enroll

Course Description

The dramatic increase in opioid overdose deaths across the nation, tied to stimulant and fentanyl use, highlights the need for rapid expansion of access to intervention services in a variety of healthcare and community health settings across the state. This session is part of a larger series of Clinical Quick Tips that UCLA ISAP has prepared for providers working in Primary Care and Community Health settings to help them better understand: patterns of use and risk of stimulants and fentanyl; tools for identifying use among patients; approaches for engaging and supporting patients to help reduce harmful consequences of use; linkages and pathways to specialty care when desired; and medication supports for patients with co-occurring mental health issues.

This 15-minute on-demand course addresses current trends in stimulant use in California and nationally, and reviews the physical and psychiatric consequences of use. Primary care settings present opportunities for providers to engage patients who use stimulants and/or fentanyl into care. Retention in care and reducing harmful impacts of stimulant use are critical.

Launch Date: December 6, 2022

At the conclusion of the on-demand course, participants will be able to:

  1. Recognize at least two (2) medical consequences of stimulant use.
  2. Identify at least two (2) clinical challenges in addressing stimulant use among their patient population.

Instructions for Continuing Education Credits

How to receive a CME certificate:

For Continuing Medical Education (CME) for physicians, physician assistants, nurses, and nurse practitioners only, you will receive a link to complete the course evaluation for CME after watching the video for this course, and you will receive your CE certificate via email within six to eight weeks.

If you have any UCLA ISAP CME-related questions, please contact Gloria Miele at gmiele@mednet.ucla.edu.

CME Statements:

Please view the linked CME Learner Handout for more information about how to obtain CME credit.

The training course meets the qualifications for the provision of one quarter (0.25) continuing medical education credit/contact hour (CME/CEH).

UCLA Integrated Substance Abuse Programs (ISAP) is accredited by the California Medical Association (CMA) to provide continuing medical education for physicians.

UCLA Integrated Substance Abuse Programs (ISAP) designates this learning course for a maximum of one quarter (0.25) AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The California Board of Registered Nursing recognizes that Continuing Medical Education (CME) is acceptable for meeting RN continuing education requirements as long as the course is certified for AMA PRA Category 1 CreditsTM (rn.ca.gov). Nurses will receive a Certificate of Participation following this activity that may be used for license renewal.

Continuing medical education will be awarded within 6-8 weeks following completion of the training.

Estimated time to complete the course:

This course should take approximately 15 minutes to complete.

Cost:

Free

Disclosure statements:

Richard Rawson, Ph.D

Professor Emeritus, UCLA Department of Psychiatry and Biobehavioral Sciences

Research Professor, Vermont Center for Behavior and Health, Center for Rural Addiction, University of Vermont

None of the presenters, planners, or others in control of content for this educational activity have relevant financial relationships to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

Trainer:

Richard Rawson, Ph.D

Professor Emeritus, UCLA Department of Psychiatry and Biobehavioral Sciences

Research Professor, Vermont Center for Behavior and Health, Center for Rural Addiction, University of Vermont

Recommended Audience:

This online course is recommended for primary clinicians and community health providers who are involved in providing multidisciplinary care to persons with opioid, stimulant, and other substance use disorders, including, but not limited to:

  • Physicians
  • Physician Assistants
  • Nurse Practitioners
  • Registered Nurses and LVNs
  • Medical Assistants
  • Other Primary Care and Community Health Specialists/Clinicians

Instructions for Requesting Accommodations for Disability:

If you need a disability-related reasonable accommodation/alternative format for this event, please contact Darren Manley at dmanley@mednet.ucla.edu.

Instructions for Filing a Grievance Concerning UCLA ISAP’s Continuing Education Program:

Please contact Dr. Thomas E. Freese, CE Program Administrator, in writing:(UCLA ISAP, 10911 Weyburn Ave, Suite 200, Los Angeles, CA 90024) or by phone (310-267-5397). Alternately, you may contact Dr. Gloria Miele or Dr. James Peck, ISAP-affiliated doctoral-level psychologists responsible for program planning for the ISAP CE Program. Drs. Miele and Peck can be reached in writing at: 10911 Weyburn Ave, Suite 200, Los Angeles, CA 90024 or by phone at: 310-267-5888 (Miele) or 310-267-5346 (Peck).

Please click on the lesson below to start the course.

Course Content

Expand All